Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Critical Aspects of a Sustainable Clinical Research Program in the Community-Based Oncology Practice.

Ersek JL, Graff SL, Arena FP, Denduluri N, Kim ES.

Am Soc Clin Oncol Educ Book. 2019 Jan;39:176-184. doi: 10.1200/EDBK_238485. Epub 2019 May 17.

2.

A Randomized, Open-Label, Safety and Exploratory Efficacy Study of Kanglaite Injection (KLTi) plus Gemcitabine versus Gemcitabine in Patients with Advanced Pancreatic Cancer.

Schwartzberg LS, Arena FP, Bienvenu BJ, Kaplan EH, Camacho LH, Campos LT, Waymack JP, Tagliaferri MA, Chen MM, Li D.

J Cancer. 2017 Jul 3;8(10):1872-1883. doi: 10.7150/jca.15407. eCollection 2017.

3.

CA19-9 decrease at 8 weeks as a predictor of overall survival in a randomized phase III trial (MPACT) of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic pancreatic cancer.

Chiorean EG, Von Hoff DD, Reni M, Arena FP, Infante JR, Bathini VG, Wood TE, Mainwaring PN, Muldoon RT, Clingan PR, Kunzmann V, Ramanathan RK, Tabernero J, Goldstein D, McGovern D, Lu B, Ko A.

Ann Oncol. 2016 Apr;27(4):654-60. doi: 10.1093/annonc/mdw006. Epub 2016 Jan 22.

4.

EMERGE: A Randomized Phase II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Advanced Glycoprotein NMB-Expressing Breast Cancer.

Yardley DA, Weaver R, Melisko ME, Saleh MN, Arena FP, Forero A, Cigler T, Stopeck A, Citrin D, Oliff I, Bechhold R, Loutfi R, Garcia AA, Cruickshank S, Crowley E, Green J, Hawthorne T, Yellin MJ, Davis TA, Vahdat LT.

J Clin Oncol. 2015 May 10;33(14):1609-19. doi: 10.1200/JCO.2014.56.2959. Epub 2015 Apr 6.

PMID:
25847941
5.

Everolimus plus exemestane in postmenopausal patients with HR(+) breast cancer: BOLERO-2 final progression-free survival analysis.

Yardley DA, Noguchi S, Pritchard KI, Burris HA 3rd, Baselga J, Gnant M, Hortobagyi GN, Campone M, Pistilli B, Piccart M, Melichar B, Petrakova K, Arena FP, Erdkamp F, Harb WA, Feng W, Cahana A, Taran T, Lebwohl D, Rugo HS.

Adv Ther. 2013 Oct;30(10):870-84. doi: 10.1007/s12325-013-0060-1. Epub 2013 Oct 25. Erratum in: Adv Ther. 2014 Sep;31(9):1008-9.

6.

Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine.

Von Hoff DD, Ervin T, Arena FP, Chiorean EG, Infante J, Moore M, Seay T, Tjulandin SA, Ma WW, Saleh MN, Harris M, Reni M, Dowden S, Laheru D, Bahary N, Ramanathan RK, Tabernero J, Hidalgo M, Goldstein D, Van Cutsem E, Wei X, Iglesias J, Renschler MF.

N Engl J Med. 2013 Oct 31;369(18):1691-703. doi: 10.1056/NEJMoa1304369. Epub 2013 Oct 16.

7.

Phase II multicenter trial of albumin-bound paclitaxel and capecitabine in first-line treatment of patients with metastatic breast cancer.

Schwartzberg LS, Arena FP, Mintzer DM, Epperson AL, Walker MS.

Clin Breast Cancer. 2012 Apr;12(2):87-93. doi: 10.1016/j.clbc.2011.10.004. Epub 2011 Dec 6.

PMID:
22154117
8.

Phase II, randomized trial to compare anastrozole combined with gefitinib or placebo in postmenopausal women with hormone receptor-positive metastatic breast cancer.

Cristofanilli M, Valero V, Mangalik A, Royce M, Rabinowitz I, Arena FP, Kroener JF, Curcio E, Watkins C, Bacus S, Cora EM, Anderson E, Magill PJ.

Clin Cancer Res. 2010 Mar 15;16(6):1904-14. doi: 10.1158/1078-0432.CCR-09-2282. Epub 2010 Mar 9.

9.

Severe pulmonary complications in African-American patient after bortezomib therapy.

Ohri A, Arena FP.

Am J Ther. 2006 Nov-Dec;13(6):553-5.

PMID:
17122539
10.

Do families understand "do not resuscitate" orders?

Loscalzo JJ, Cooper DJ, Arena FP, Llovera I.

Oncology (Williston Park). 1996 Apr;10(4):504, 507, 511. No abstract available.

11.
12.

Doxorubicin hypersensitivity and clindamycin.

Arena FP, Sherlock S.

Ann Intern Med. 1990 Jan 15;112(2):150. No abstract available.

PMID:
2294825
13.

Fever, rash, and myalgias of dissseminated candidiasis during antifungal therapy.

Arena FP, Perlin M, Brahman H, Weiser B, Armstrong D.

Arch Intern Med. 1981 Aug;141(9):1233. No abstract available.

PMID:
6942791
14.

Initial experience with a "code-no code" resuscitation system in cancer patients.

Arena FP, Perlin M, Turnbull AD.

Crit Care Med. 1980 Dec;8(12):733-5.

PMID:
7449404
15.

Invasive aspergillosis with massive fatal hemoptysis in patients with neoplastic disease.

Borkin MH, Arena FP, Brown AE, Armstrong D.

Chest. 1980 Dec;78(6):835-9.

PMID:
6934926
16.

Effect of a zinc-deficient diet on the growth of an IgM-secreting plasmacytoma (TEPC-183).

Fenton MR, Burke JP, Tursi FD, Arena FP.

J Natl Cancer Inst. 1980 Dec;65(6):1271-2.

PMID:
6933272
17.

Coexisting hypertrophic heart disease and mitral valve prolapse. A continuum of hereditary cardiac disease?

Rubenstein S, Christodoulou JP, Arena FP, Arditi LI, Scheidt S.

Chest. 1980 Jul;78(1):51-4.

PMID:
7193556
18.

Clinicopathology conference. A patient with ascites and hypercalcemia.

Arena FP.

Clin Bull. 1979;9(3):117-25. No abstract available.

PMID:
519858
19.

Salicylate-induced hypoglycemia and ketoacidosis in a nondiabetic adult.

Arena FP, Dugowson C, Saudek CD.

Arch Intern Med. 1978 Jul;138(7):1153-4.

PMID:
666481
20.

Genetic control.

Guttentag OE, Lappé M, FitzGerald JA, Schweitzer PE, Arena FP, Fletcher J.

N Engl J Med. 1972 Jan 6;286(1):48-50. No abstract available.

PMID:
5006932

Supplemental Content

Loading ...
Support Center